Baseline characteristics | N = 187 | Percentage |
---|---|---|
Male | 120 | 64.2% |
Female | 67 | 35.8% |
Age | 68 [23–90] y* | – |
Spondylodiscitis | 125 | 66.8% |
Isolated spinal epidural empyema | 62 | 33.2% |
Gram-positive bacteria | 162/187 | 86.6% |
Gram-negative bacteria | 25/187 | 13.4% |
Surgery | 187 | 100% |
Blood cultures | 187 | 100% |
Psoas abscess | 116 | 62.0% |
CT-guided biopsy of Psoas | 65/116 | 56.0% |
Empiric antibiotic therapy (EAT) | 122 | 65.2% |
Targeted antibiotic therapy (TAT) | 65 | 34.8% |
Duration of intravenous antibiotics | 4 [3–6] w* | – |
Duration of total antibiotics | 8 [6–12] w* | – |
Sepsis | 94/187 | 50.3% |
Septic embolism | 50/150 | 33.3% |
Infective endocarditis with vegetation in TTE/TEE | 23/161 | 14.3% |
Relapse rate (clinical, microbiological, and/or radiological progression) | 28/123 | 22.8% |
Disease-related mortality | 10/187 | 5.3% |